Prevalence and risk factors of low bone mineral density and 25-hydroxyvitamin D status in young healthy epileptic adult patients in a tropical Asian country taking antiepileptic drug

Bone

Volumn 45, Issue 2, 2009, Pages 232-237

  Phabphal, Kanitpong ^a   Geater, Alan ^a   Leelawattana, Rattana ^a   Sathirapunya, Ponchi ^a   Sattawatcharawanich, Suwanna ^a   Limapichat, Kitti ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Antiepileptic drug; Bone; Thailand; Vitamin D; Young adult

Indexed keywords

25 HYDROXYVITAMIN D; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; GABAPENTIN; LAMOTRIGINE; PARATHYROID HORMONE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; BONE DENSITY; CONTROLLED STUDY; EPILEPSY; FEMALE; FEMUR NECK; GENDER; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SIDE EFFECT; SPINE; TREATMENT DURATION; TROPICS; VITAMIN D DEFICIENCY;

ADULT; ANTICONVULSANTS; BODY MASS INDEX; BONE DENSITY; DEMOGRAPHY; EPILEPSY; FEMALE; HEALTH; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARATHYROID HORMONE; PREVALENCE; RISK FACTORS; THAILAND; TIME FACTORS; TROPICAL CLIMATE; VITAMIN D;

EID: 67649635639     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.04.235     Document Type: Article

References (35)

1. Kruse C.A. Osteopathies in antiepileptic long-term therapy (preliminary report). Monatsschr. Kinderheilkd. 116 (1968) 378-381
2. Lado F., Spiegel R., Masur J.H., Boro A., and Haut S.R. Value of routine screening for bone demineralization in an urban population of patients with epilepsy. Epilepsy Res. 78 (2008) 155-160
3. El-Hajj Fuleihan G., Dib L., Yamout B., Sawaya R., and Mikati M.A. Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone 29 (2008) 1586-1593
4. Farhat G., Yamout B., Mikati M.A., Demirjian S., Sawaya R., and El-Hajj Fuleihan G. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 58 (2002) 1348-1353
5. Kulak C.A., Borba V.Z., Bilezikian J.P., Silvado C.E., Paola L., and Boguszewski C.L. Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs. Arq. Neuropsiquiatr. 62 (2004) 940-948
6. Pack A.M., Olarte L.S., Morrell M.J., Flaster E., Resor S.R., and Shane E. Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav. 4 (2003) 169-174
7. Andress D.L., Ozuna J., Tirschwell D., Grande L., Johnson M., Jacobson A.F., et al. Antiepileptic drug-induced bone loss in young male patients who have seizure. Arch. Neurol. 59 (2002) 781-786
8. Sato Y., Kondo I., Ishida S., Motooka H., Takayama K., Tomita Y., et al. Decreased bone mass and increased bone turnover with valproate therapy in adult with epilepsy. Neurology 57 (2001) 445-449
9. Phabphal K., Limapichat K., Sathirapanya P., Setthawatcharawanich S., Leelawattana R., Thammakumpee N., et al. Bone mineral density following long-term use of antiepileptic drugs in a tropical Asian country. Epileptic. Disord. 10 (2008) 213-218
10. Tolman K.G., Jubiz W., and Sannella J.J. Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children. Pedritrics 56 (1975) 45-51
11. Sotaniemi E.A., Hakkarainen H.K., Puanen J.A., and Lahti R.O. Radiologic bone changes and hypocalcemia with anticonvulsant therapy in epilepsy. Ann. Intern. Med. 77 (1972) 389-394
12. Ongphiphadhanakul B. Osteoporosis in Thailand. Clin. Calcium 12 (2002) 822-826
13. Stephen L.J., McLellan A.R., Harrison J.H., Shapiro D., Dominiczak M.H., Sills G.J., et al. Bone density and antiepileptic drugs: a case-controlled study. Seizure 8 (1999) 339-342
14. Pack A.M., Morrell M.J., Randall A., McMahon D.J., and Shane E. Bone health in young woman with epilepsy after one year of antiepileptic drug monotherapy. Neurology 70 (2008) 1586-1593
15. Sheth R.D., Wesolowski C.A., Jacob J.C., Penney S., Hobbs G.R., Riggs J.E., et al. Effect of carbamazepine and valproate on bone mineral density. J. Pediatr. 127 (1995) 256-262
16. Petty S.J., Paton L.M., O Brien T.J., Makovey J., Erbas B., Sambrook P., et al. Effect of antiepileptic medication on bone mineral measures. Neurology 65 (2005) 1358-1365
17. World Health Organization, International Association for the Study of Obesity, International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment (2000), Sydney Health Communications
18. Alekel D.L., Mortillaro E., Hussain E.A., West B., Ahmed N., Peterson C.T., et al. Lifestyle and biologic contributors to proximal femur bone mineral density and hip axis length in two distinct ethnic groups of premenopausal woman. Osteoporos Int. 9 (1999) 327-338
19. Ward K.A., Roy D.K., Pye S.R., O Neill T.W., Berry J.L., Swarbrick C.M., et al. Forearm bone geometry and mineral content in UK woman of European and South-Asian origin. Bone 41 (2007) 117-121
20. Marshall L.M., Zmuda J.M., Chan B.K., Barrett-Connor E., Cauley J.A., Ensrud K.E., et al. Race and ethnic variation in proximal femur structure and BMD among older men. J. Bone Miner. Res. 23 (2008) 121-130
21. Holic M.F. Vitamin D deficiency. N. Engl. J. Med. 357 (2007) 226-281
22. Zhou C., Assem M., Tay J.C., Watkins P.B., Blumberg B., Schuetz E.G., et al. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J. Clin. Invest. 116 (2006) 1703-1786
23. Hanth T.J. Steroid and drug-induced osteopenia. In: Favus M.J., and et a. (Eds). Primer on the metabolic bone disease and disorders of mineral metabolism (1993), Raven Press, New York 250-255
24. Parfitt A.M., Gallagher J.C., Heaney R.P., Johnston C.C., Neer R., and Whedon G.D. Vitamin D and bone health in the elderly. Am. J. Clin. Nutr. 36 (1982) 1014-1031
25. Hahn T.J., Hendin B.A., Scharp C.R., and Haddad Jr. J.G. Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol level in adults. N. Engl. J. Med. 287 (1972) 900-904
26. Bouillon R., Reynaert J., Claes J.H., Lissens W., and De Moor P. The effect of anticonvulsant therapy on serum levels of 25-hydroxy-vitamin D, calcium, and parathyroid hormone. J. Clin. Endocrinol. Metab. 41 (1975) 1130-1135
27. Ensrud K.E., Walczak T.S., Blackwell T., Ensrud E.R., Bowman P.J., and Ston K.L. Antiepileptic drug use increases rates of bone loss in older woman: a prospective study. Neurology 62 (2004) 2051-2057
28. Akin R., Okutan V., Sarici U., Altunbas A., and Gökçay E. Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr. Neurol. 19 (1998) 129-131
29. Verrotti A., Greco R., Latini G., Morgese G., and Chiarelli F. Increase bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamacepine. Epilepsia 43 (2002) 1488-1492
30. Ben-Menachem E. Weight issues for people with epilepsy-a review. Epilepsia 48 Suppl 9 (2007) 42-45
31. Aydin K., Serdaroglu A., Okuyaz C., Bideci A., and Gucuyener K. Serum insulin, leptin, and neuropeptide y levels in epileptic children treated with valproate. J. Child. Neurol. 20 (2005) 848-851
32. Sheth R.D., Binkley N., and Hermann B.P. Gender differences in bone mineral density in epilepsy. Epilepsia 49 (2008) 125-131
33. Kubota F., Kifune A., Shibata N., Akata T., Takeuchi K., Ohsawa M., et al. Bone mineral density of epileptic patients on long-term antiepileptic drug therapy: a quantitative digital radiography study. Epilepsy. Res. 33 (1999) 93-97
34. Stevenson J.C., Whitehead M.I., Padwick M., Endacott J.A., Sutton C., Banks L.M., et al. Dietary intake of calcium and postmenopausal bone loss. BMJ 297 (1988) 15-17
35. Angus R.M., Sambrook P.N., Pocock N.A., and Eisman J.A. Dietary intake and bone mineral density. Bone Miner. 4 (1988) 265-277